The xc− cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistanceMaisie Lo, Peter W. Gout|British Journal of Cancer|2008Cited by 229
Patient-Derived First Generation Xenografts of Non–Small Cell Lung Cancers: Promising Tools for Predicting Drug Responses for Personalized ChemotherapyXin Dong, Yuzhuo Wang, Jun Guan et al.|Clinical Cancer Research|2010Cited by 195
The x c − cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazineJun Guan, Yuzhuo Wang, Arthur R. Buckley et al.|Cancer Chemotherapy and Pharmacology|2008Cited by 131
Establishment in Severe Combined Immunodeficiency Mice of Subrenal Capsule Xenografts and Transplantable Tumor Lines from a Variety of Primary Human Lung Cancers: Potential Models for Studying Tumor Progression–Related ChangesJean‐Claude Cutz, Yuzhuo Wang, Jun Guan et al.|Clinical Cancer Research|2006Cited by 107